AADI BIOSCIENCE, INC.

(AADI)
  Rapport
Temps Différé Nasdaq  -  22:00 24/06/2022
12.16 USD   -8.23%
23/06Aadi Bioscience rejoint les indices Russell 2000 et Russell 3000
MT
31/05Aadi Bioscience nomme Marcy Graham vice-présidente principale des relations avec les investisseurs et des communications d'entreprise
CI
26/05Aadi Bioscience, Inc. annonce que des données exploratoires sur les biomarqueurs provenant des patients de son essai AMPECT et de son programme d'accès élargi seront présentées au congrès annuel de l'ASCO en 2022
CI
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFonds 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur AADI BIOSCIENCE, INC.
24/06AADI BIOSCIENCE : Corporate Overview
24/06Aadi Bioscience to Join Russell 2000 and Russell 3000 Indexes
24/06AADI BIOSCIENCE, INC.(NASDAQCM : AADI) added to Russell 2500 Growth Index
24/06AADI BIOSCIENCE, INC.(NASDAQCM : AADI) added to Russell 2000 Growth Index
24/06AADI BIOSCIENCE, INC.(NASDAQCM : AADI) dropped from Russell Microcap Value Index
24/06AADI BIOSCIENCE, INC.(NASDAQCM : AADI) added to Russell 2000 Dynamic Index
24/06AADI BIOSCIENCE, INC.(NASDAQCM : AADI) added to Russell 2000 Index
24/06AADI BIOSCIENCE, INC.(NASDAQCM : AADI) added to Russell 2500 Index
24/06AADI BIOSCIENCE, INC.(NASDAQCM : AADI) added to Russell Small Cap Comp Growth Index
24/06AADI BIOSCIENCE, INC.(NASDAQCM : AADI) added to Russell 3000 Growth Index
24/06AADI BIOSCIENCE, INC.(NASDAQCM : AADI) added to Russell 3000E Index
24/06AADI BIOSCIENCE, INC.(NASDAQCM : AADI) added to Russell 3000E Growth Index
24/06AADI BIOSCIENCE, INC.(NASDAQCM : AADI) added to Russell 3000 Index
24/06AADI BIOSCIENCE, INC.(NASDAQCM : AADI) added to Russell Small Cap Completeness Index
24/06AADI BIOSCIENCE, INC.(NASDAQCM : AADI) dropped from Russell 3000E Value Index
23/06Aadi Bioscience to Join Russell 2000, Russell 3000 Indexes
23/06Aadi Bioscience to Join Russell 2000® and Russell 3000® Indexes
17/06AADI BIOSCIENCE, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
01/06Aadi Bioscience to Present at the Jefferies Global Healthcare Conference
31/05Aadi Bioscience Appoints Marcy Graham Senior Vice President Investor Relations and Corp..
31/05Aadi Bioscience Appoints Marcy Graham Senior Vice President Investor Relations and Corp..
26/05Aadi Bioscience Announces Exploratory Biomarker Data from Patients in Its AMPECT Trial ..
26/05Aadi Bioscience, Inc. Announces Exploratory Biomarker Data from Patients in Its AMPECT ..
18/05Aadi Bioscience to Present at the H.C. Wainwright Global Investment Conference
12/05AADI BIOSCIENCE, INC. Management's Discussion and Analysis of Financial Condition and ..
12/05Earnings Flash (AADI) AADI BIOSCIENCE Reports Q1 Revenue $2.3M
12/05TRANSCRIPT : Aadi Bioscience, Inc., Q1 2022 Earnings Call, May 12, 2022
12/05Aadi Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 20..
12/05Earnings Flash (AADI) AADI BIOSCIENCE Reports Q1 Revenue $2.3M, vs. Street Est of $0.41..
12/05Aadi Bioscience Reports First Quarter 2022 Financial Results and Provides a Corporate U..
09/05Aadi Bioscience Announces Collaborations with Next Generation Sequencing Leaders
09/05Aadi Bioscience Announces Collaborations with Next Generation Sequencing Leaders
05/05Aadi Bioscience Announces Unique Permanent J-code Issued for FYARRO from Centers for Me..
04/05Aadi Bioscience Announces Unique Permanent J-code Issued for FYARRO™ from Centers..
04/05Aadi Bioscience Announces Unique Permanent J-code Issued for FYARRO™ from Centers ..
28/04Aadi Bioscience to Announce First Quarter 2022 Financial Results on May 12, 2022
19/04Aadi Bioscience to Participate at the Jefferies 'Biotech on the Bay' Summit
18/04Aadi Bioscience to Participate at the Jefferies “Biotech on the Bay” Summit
08/04Aadi Bioscience Announces Data Presentation on incidence of TSC1 and TSC2 Alterations i..
08/04Aadi Bioscience, Inc. Announces Data Presentation on Incidence of TSC1 and TSC2 Alterat..
31/03Aadi Bioscience Announces First Patient Dosed in its PRECISION 1 Phase 2 Registrational..
31/03Aadi Bioscience, Inc. Announces First Patient Dosed in its PRECISION 1 Phase 2 Registra..
18/03SECTOR UPDATE : Health Care Stocks Hold Investor Support at Close
18/03SECTOR UPDATE : Health Care Stocks Back on Positive Ground on Friday
17/03Aadi Bioscience Plans Share Offering With Maximum Gross Proceeds of $75 Million
17/03AADI BIOSCIENCE, INC. : Entry into a Material Definitive Agreement, Financial Statements a..
17/03AADI BIOSCIENCE, INC. Management's Discussion and Analysis of Financial Condition and ..
17/03Aadi Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 202..
17/03AADI BIOSCIENCE : Reports Fourth Quarter and Full Year 2021 Financial Results and Provides..
17/03Aadi Bioscience, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31..
17/03Aadi Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business ..
07/03AADI BIOSCIENCE : Corporate Overview
02/03Aadi Bioscience to Participate in Panel Discussion on Tumor-Agnostic Development at Cow..
01/03Aadi Bioscience to Participate in Panel Discussion on Tumor-Agnostic Development at Cow..
24/02Aadi Bioscience Announces U.S. Commercial Launch and Availability of FYARRO for the Tre..
23/02Aadi Launches Oncology Drug FYARRO in US
23/02Aadi Bioscience Announces U.S. Commercial Launch and Availability of FYARRO™ for ..
23/02Aadi Bioscience, Inc. Announces U.S. Commercial Launch and Availability of FYARRO™..
20/01AADI BIOSCIENCE : Material Definitive Agreement - Form 8-K
20/01Aadi Bioscience, Inc. Enters into Certain Negotiated Purchase Order Terms and Condition..
20/01AADI BIOSCIENCE, INC. : Entry into a Material Definitive Agreement (form 8-K)
20/01Canadian Biotech Disruptor Lexston Life Sciences is unlocking the God Molecule (LEXTF, ..
04/01Aadi Bioscience to Present at 2022 H.C. Wainwright BioConnect Virtual Conference
2021AADI BIOSCIENCE, INC.(NASDAQCM : AADI) added to S&P Biotechnology Select Industry Index
2021AADI BIOSCIENCE : Corporate Overview
2021Health Care Stocks Nudging Back Onto Positive Ground
2021Health Care Stocks Partially Recover From Morning Slide
2021SECTOR UPDATE : Health Care
2021Aadi Bioscience Shares Drop 5% After FDA Approves Tumor Treatment Fyarro
2021Health Care Stocks Flat Ahead of Tuesday's Opening Bell
2021SECTOR UPDATE : Health Care
2021Top Premarket Gainers
2021AADI BIOSCIENCE : Announces FDA Approval of its First Product FYARRO™ for Patients wi..
2021AADI BIOSCIENCE, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
2021Aadi Bioscience Gets FDA Approval for Cancer-Treatment Fyarro
1  2Suiv.